Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Total Non-Current Liabilities (2023 - 2025)

Metagenomi (MGX) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $60.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 30.98% to $60.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $60.6 million, a 30.98% decrease, with the full-year FY2025 number at $60.6 million, down 30.98% from a year prior.
  • Total Non-Current Liabilities was $60.6 million for Q4 2025 at Metagenomi, down from $67.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $144.6 million in Q4 2023 to a low of $60.6 million in Q4 2025.
  • A 3-year average of $96.1 million and a median of $87.7 million in 2024 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 39.32% in 2024, then plummeted 30.98% in 2025.
  • Metagenomi's Total Non-Current Liabilities stood at $144.6 million in 2023, then crashed by 39.32% to $87.7 million in 2024, then tumbled by 30.98% to $60.6 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Total Non-Current Liabilities are $60.6 million (Q4 2025), $67.6 million (Q3 2025), and $74.3 million (Q2 2025).